the relationship between omega-5 gliadin specific IgE titer and maintenance dose of rush oral immunotherapy of wheat allergy

the relationship between omega-5 gliadin specific IgE titer and maintenance dose of rush oral immunotherapy of wheat allergy - rush oral immunotherapy of wheat allergy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033391

Enrollment

Registered

2018-07-14

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wheat allergy patients

Interventions

30g of meintenance dose choice of 5g,10g or 30g of maintenance dose according to omega-5 gliadin specific IgE titer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: wheat allergy

Exclusion criteria

Exclusion criteria: rash immunotherapy of other food heat,liver and kidney disease uncontrolled bronchial asthma and atopic dermatitis IgA deficiency

Design outcomes

Primary

Measure	Time frame
Comparison of the number of days of provoked symptoms Comparison of reaching the maintenance dose in the build-up phase	—

Countries

Japan

Contacts

Public ContactYuri Takaoka

osaka Habikino medical center department of pediatrics

zvb11075@nifty.com0729572121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026